Valuation: Cipla Limited

Market Cap 1,07000Cr 1.13TCr 1TCr 929.29Cr 845.49Cr 1.6TCr 1.62TCr 11TCr 4.38TCr 56TCr 4.23TCr 4.14TCr 1,78100Cr P/E 2027 *
25.8x
P/E 2028 * 20.8x
Enterprise Value 96TCr 1.02TCr 903.24Cr 837.18Cr 761.69Cr 1.44TCr 1.46TCr 10TCr 3.95TCr 50TCr 3.81TCr 3.73TCr 1,60400Cr EV / Sales 2027 *
3.12x
EV / Sales 2028 * 2.71x
Free-Float
68.87%
Yield 2027 *
0.98%
Yield 2028 * 1.11%
1 day-0.22%
1 week+1.85%
Current month-1.55%
1 month-2.42%
3 months-7.30%
6 months+7.69%
Current year-12.32%
1 week 1,300.2
Extreme 1300.2
1,337.5
1 month 1,292
Extreme 1292
1,421
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
Director of Finance/CFO - 24/07/2026
President - 18/05/2026
Director TitleAgeSince
Chairman 90 21/07/1972
Director/Board Member 72 25/07/2014
Director/Board Member 71 30/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
22/08/24 Sell 2,000 0.0002%
14/08/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.22%+1.85%-15.57%+13.80% 1.13TCr
+0.43%+6.59%+53.41%+103.85% 1,12000Cr
+0.90%-2.25%+33.02%+62.23% 62TCr
+0.71%+3.24%+25.81%+93.86% 50TCr
-0.13%+5.98%+32.91%+50.39% 37TCr
+0.52%+0.24%+73.92%+40.15% 36TCr
-0.95%+4.70%+19.51%+43.00% 29TCr
-1.98%+3.73%-0.86%+13.43% 26TCr
-0.35%+4.25%+46.21%+50.76% 23TCr
-0.75%+3.32%+32.53%+97.21% 19TCr
Average -0.18%+3.44%+30.09%+56.87% 39.52TCr
Weighted average by Cap. +0.13%+3.83%+39.02%+71.27%

Financials

2027 *2028 *
Net sales 31TCr 325.89Cr 289.69Cr 268.5Cr 244.29Cr 460.98Cr 468.37Cr 3.23TCr 1.27TCr 16TCr 1.22TCr 1.2TCr 51TCr 35TCr 365.43Cr 324.83Cr 301.08Cr 273.93Cr 516.91Cr 525.2Cr 3.62TCr 1.42TCr 18TCr 1.37TCr 1.34TCr 58TCr
Net income 4.12TCr 43Cr 39Cr 36Cr 33Cr 61Cr 62Cr 429.73Cr 168.49Cr 2.15TCr 162.85Cr 159.38Cr 6.85TCr 5.16TCr 54Cr 48Cr 45Cr 41Cr 77Cr 78Cr 538.33Cr 211.07Cr 2.69TCr 204.01Cr 199.66Cr 8.58TCr
Net Debt -11TCr -111.8Cr -99Cr -92Cr -84Cr -158.14Cr -160.67Cr -1.11TCr -434.09Cr -5.54TCr -419.57Cr -410.64Cr -18TCr -13TCr -138.5Cr -123.12Cr -114.11Cr -103.82Cr -195.92Cr -199.06Cr -1.37TCr -537.79Cr -6.86TCr -519.8Cr -508.73Cr -22TCr
Projected Income Statement - Annual - Cipla Limited
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
16/26/16 ₹1,325.10 -0.22% 8,50,284
15/26/15 ₹1,328.00 +1.02% 13,71,747
14/26/14 ₹1,314.60 -1.13% 9,94,166
13/26/13 ₹1,329.60 +1.40% 4,78,066
12/26/12 ₹1,311.30 +0.79% 6,66,122
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Cipla Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,325.10INR
Average target price
1,512.19INR
Spread / Average Target
+14.12%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cipla Limited
  1. Stock Market
  2. Stocks
  3. CIPLA Stock